Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Verrica Pharmaceuticals Inc. (VRCA) had Receiveable Turnover of 0.61 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$3.44M |
|
$-9.74M |
|
$0.44M |
|
$3.00M |
|
$11.57M |
|
$-8.13M |
|
$-1.61M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-8.13M |
|
$-7.92M |
|
94.84M |
|
94.84M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$39.47M |
|
$0.54M |
|
$2.70M |
|
$42.18M |
|
$29.40M |
|
$28.46M |
|
$31.36M |
|
$60.75M |
|
$-18.58M |
|
$-18.58M |
|
$-18.58M |
|
91.79M |
|
| Cash Flow Statement Financials | |
$-12.68M |
|
-- |
|
$-4.06M |
|
$46.33M |
|
$29.59M |
|
$-16.73M |
|
$1.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.34 |
|
-- |
|
-- |
|
2.88 |
|
-2.24 |
|
87.29% |
|
-236.41% |
|
-236.41% |
|
-- |
|
-283.28% |
|
-283.28% |
|
$-12.68M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.18 |
|
|
Receiveable Turnover |
0.61 |
147.94 |
|
52.44% |
|
52.44% |
|
-23.10% |
|
-98.52% |
|
$-0.20 |
|
$-0.13 |
|
$-0.13 |
|